FDA-News

FDA Warns, Male Enhancement Products May Be Dangerous

FDA has furnished a warning letter regarding the male enhancement products which are unapproved and available at gas stations. It…

6 years ago

FDA Committee Recommends First Marijuana-Derived Drug

First prescription cannabidiol medicine has been voted by Federal Advisors for recommendation to get approval for treating epilepsy. Even the…

6 years ago

‘Biosimilar’ drug Ogviri approved by FDA for breast and stomach cancer

For the treatment of certain breast and stomach cancers, the U.S. Food and Drug Administration (FDA) recently approved Ogiviri (tastuzumab-dkst),…

7 years ago

Monthly dose of Buprenorphine for treating opioid addiction, approved by FDA

U.S. Food and Drug Administration has approved a once in a month injection of Buprenorphine for the treatment of opioid…

7 years ago

FDA approves Helimbra, new drug to prevent bleeding episodes in Hemophilia A patients

The U.S. Food and Drug Administration (FDA) has approved Helimbra (Emicizumab-kxwh) for preventing or reducing bleeding episodes in some patients…

7 years ago

FDA approves nerve stimulator for people facing opioid withdrawal symptoms

For reducing the symptoms of opioid withdrawal, a novel device has been approved by the U.S. Food and Drug Administration…

7 years ago

FDA approves Mepsevii for Sly syndrome – a rare enzyme disorder

For the treatment of a rare, genetic disease, known as mucopolysaccharidosis type VII or Sly syndrome, a drug, named Mepsevii…

7 years ago

Kratom has its own share of cons, warns FDA

Recently, the U.S. Food and Drug Administration (FDA) has issued warning related to the harmful effects of kratom – a…

7 years ago

FDA approves Ascor for scurvy treatment

A wholly owned subsidiary of McGuff Company, Inc., McGuff Pharmaceuticals, Inc. has recently announced the approval of Ascor (Ascorbic Acid…

7 years ago

FDA approves Idhifa for a specific type of acute myeloid leukemia

The U.S. FDA has recently approved a drug, named Idhifa (enasidenib) to cure patients with genetic mutation resulting in relapsed…

7 years ago

FDA approves Calquence for the treatment of mantle cell lymphoma

Basically, a cancer of lymph system, mantle cell is a highly invasive, non-Hodgkin lymphoma. According to a news release, the…

7 years ago